Abbas Hussain
Director · Moderna, Inc.
IndividualSelling only3 10b5-1 trades
- 2024
- May 8, 2026
- 5
Filings (90d)
0
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Abbas Hussain files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Stephane Bancel - $28.72M in MRNA purchases and sales in the last 12 months
- Stephen Hoge - $28.43M in MRNA purchases and sales in the last 12 months
- James M. Mock - $4.69M in MRNA purchases and sales in the last 12 months
- Shannon Thyme Klinger - $1.39M in MRNA purchases and sales in the last 12 months
- Noubar Afeyan - $434K in MRNA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Abbas Hussain?
Abbas Hussain is a corporate insider, tracked as Director of Moderna, Inc. (MRNA). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Abbas Hussain last file a Form 4?
The most recent primary Form 4 on record is dated 8 May 2026, one of 5 filings going back to 2024.
Has Abbas Hussain been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($265K) across all tracked filings.
